The future of cell analysis.
At Rivercyte, we produce technology for the analysis of physical phenotypes of cells, including their deformability – information largely missing in current biological and medical research.
We envision that in the future, insights about the physical phenotype of cells will be informing decisions in clinical practice.
We aim to democratize the technology for physical phenotyping of cells. We strive to make it widely available by offering affordable devices and consumables.
Tumour biopsy diagnostics using physical phenotyping of cells from tissues – new article out in Nature Biomedical Engineering
In this article published in Nature Biomedical Engineering, Soteriou and Kubankova et al. demonstrate the potential of physical phenotyping of cells for tumour biopsy diagnostics. With this approach, the physical phenotypes of singularised suspended cells dissociated from the tissue biopsy samples are analysed within 30 minutes. This sets the grounds for a new alternative to histopathological consultation during surgery, reducing time, labour and costs spent.Read more
Physical phenotypes of cells are altered during COVID-19
Using deformability cytometry, Kubánková et al., at the Max-Planck-Zentrum für Physik und Medizin in Erlangen, were able to show for the first time: COVID-19 significantly changes the size and stiffness of red and white blood cells - sometimes over months. These results may help to explain why some affected people continue to experience symptoms long after an infection (long COVID).Read more
Revolutionising cell-based diagnostics: Medical Valley Award won by interdisciplinary team of physicists, engineers and doctors
The mechanical properties of cells can reveal which diseases a patient is suffering from. Researchers at the Max-Planck-Zentrum für Physik und Medizin in Erlangen are taking advantage of this effect - and revolutionizing diagnostics. Their goal: instead of analyzing blood samples in few central labs, doctors should be able to do that quickly and reliably at the point-of-care. The RAPID Diagnostics project has now received the Medical Valley Award worth 250,000 euros.Read more